BPMC – blueprint medicines corporation (US:NASDAQ)
Stock Stats
News
Blueprint Medicines Co. (NASDAQ: BPMC) was upgraded by analysts at Leerink Partnrs from an "underperform" rating to a "market perform" rating.
Blueprint Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Blueprint Medicines Co. (NASDAQ: BPMC) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $121.00 to $168.00. They now have a "buy" rating on the stock.
Blueprint Medicines Co. (NASDAQ: BPMC) was upgraded by analysts at SVB Leerink LLC from an "underperform" rating to a "market perform" rating. They now have a $97.00 price target on the stock, up previously from $50.00.
Blueprint Medicines: Rampant Growth Mostly Priced In [Seeking Alpha]
Form 4 Blueprint Medicines Corp For: May 02 Filed by: Landsittel Michael
Form 4 Blueprint Medicines Corp For: May 02 Filed by: Hurley Ariel
Form 10-Q Blueprint Medicines Corp For: Mar 31
Form 144 Blueprint Medicines Corp Filed by: Landsittel Michael
Form 144 Blueprint Medicines Corp Filed by: Hurley Ariel
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.